stella
beta
Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod — Stella
Recruiting
Back to HSIL, High-Grade Squamous Intraepithelial Lesions trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
Brazil
Barretos Cancer Hospital, Barretos
View full record on ClinicalTrials.gov